Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 204

The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.

Modulatory mechanisms controlling the NLRP3 inflammasome in inflammation: recent developments

Haneklaus, Moritz, O’Neill, Luke AJ, Coll, Rebecca C·2013·Current Opinion in Immunology
DOI 10.1016/j.coi.2012.12.004
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.coi.2012.12.004

Cites

15 of 15 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 15 references

Research works printed but not linked: 40

  1. Wen, 2012, A role for the NLRP3 inflammasome in metabolic diseases—did Warburg miss inflammation?, Nat Immunol, 13, 352, 10.1038/ni.2228 · DOI · Paper page
  2. Tschopp, 2010, NLRP3 inflammasome activation: the convergence of multiple signalling pathways on ROS production?, Nat Rev Immunol, 10, 210, 10.1038/nri2725 · DOI · Paper page
  3. Neven, 2008, Cryopyrinopathies: update on pathogenesis and treatment, Nat Clin Pract Rheumatol, 4, 481, 10.1038/ncprheum0874 · DOI · Paper page
  4. Dinarello, 2012, Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases, Nat Rev Drug Discov, 11, 633, 10.1038/nrd3800 · DOI · Paper page
  5. Bauernfeind, 2009, Cutting edge: NF-kappaB activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression, J Immunol, 183, 787, 10.4049/jimmunol.0901363 · DOI · Paper page
  6. Juliana, 2012, Non-transcriptional priming and deubiquitination regulate NLRP3 inflammasome activation, J Biol Chem, 287, 36617, 10.1074/jbc.M112.407130 · DOI · Paper page
  7. Meissner, 2008, Superoxide dismutase 1 regulates caspase-1 and endotoxic shock, Nat Immunol, 9, 866, 10.1038/ni.1633 · DOI · Paper page
  8. Tassi, 2009, Pathogen-induced interleukin-1beta processing and secretion is regulated by a biphasic redox response, J Immunol, 183, 1456, 10.4049/jimmunol.0900578 · DOI
  9. Carta, 2011, The rate of interleukin-1beta secretion in different myeloid cells varies with the extent of redox response to Toll-like receptor triggering, J Biol Chem, 286, 27069, 10.1074/jbc.M110.203398 · DOI
  10. Shi, 2012, Activation of autophagy by inflammatory signals limits IL-1beta production by targeting ubiquitinated inflammasomes for destruction, Nat Immunol, 13, 255, 10.1038/ni.2215 · DOI · Paper page
  11. Haneklaus, 2012, Cutting edge: miR-223 and EBV miR-BART15 regulate the NLRP3 inflammasome and IL-1beta production, J Immunol, 189, 3795, 10.4049/jimmunol.1200312 · DOI · Paper page
  12. Bauernfeind, 2012, NLRP3 inflammasome activity is negatively controlled by miR-223, J Immunol, 189, 4175, 10.4049/jimmunol.1201516 · DOI · Paper page
  13. Chen, 2004, MicroRNAs modulate hematopoietic lineage differentiation, Science, 303, 83, 10.1126/science.1091903 · DOI · Paper page
  14. Johnnidis, 2008, Regulation of progenitor cell proliferation and granulocyte function by microRNA-223, Nature, 451, 1125, 10.1038/nature06607 · DOI · Paper page
  15. Gram, 2012, Inflammasomes and viruses: cellular defence versus viral offence, J Gen Virol, 93, 2063, 10.1099/vir.0.042978-0 · DOI
  16. Gregory, 2011, Discovery of a viral NLR homolog that inhibits the inflammasome, Science, 331, 330, 10.1126/science.1199478 · DOI · Paper page
  17. Komune, 2011, Measles virus V protein inhibits NLRP3 inflammasome-mediated interleukin-1beta secretion, J Virol, 85, 13019, 10.1128/JVI.05942-11 · DOI
  18. Dorfleutner, 2007, A Shope Fibroma virus PYRIN-only protein modulates the host immune response, Virus Genes, 35, 685, 10.1007/s11262-007-0141-9 · DOI
  19. Johnston, 2005, A poxvirus-encoded pyrin domain protein interacts with ASC-1 to inhibit host inflammatory and apoptotic responses to infection, Immunity, 23, 587, 10.1016/j.immuni.2005.10.003 · DOI · Paper page
  20. Savard, 2000, Infection of primary human monocytes by Epstein–Barr virus, J Virol, 74, 2612, 10.1128/JVI.74.6.2612-2619.2000 · DOI
  21. Bauernfeind, 2011, Inflammasomes: current understanding and open questions, Cell Mol Life Sci, 68, 765, 10.1007/s00018-010-0567-4 · DOI · Paper page
  22. Franchi, 2009, Cutting edge: TNF-alpha mediates sensitization to ATP and silica via the NLRP3 inflammasome in the absence of microbial stimulation, J Immunol, 183, 792, 10.4049/jimmunol.0900173 · DOI · Paper page
  23. Schroder, 2012, Acute lipopolysaccharide priming boosts inflammasome activation independently of inflammasome sensor induction, Immunobiology, 217, 1325, 10.1016/j.imbio.2012.07.020 · DOI · Paper page
  24. Qu, 2012, Phosphorylation of NLRC4 is critical for inflammasome activation, Nature, 490, 539, 10.1038/nature11429 · DOI · Paper page
  25. Lu, 2012, Novel role of PKR in inflammasome activation and HMGB1 release, Nature, 488, 670, 10.1038/nature11290 · DOI · Paper page
  26. Gross, 2009, Syk kinase signalling couples to the Nlrp3 inflammasome for anti-fungal host defence, Nature, 459, 433, 10.1038/nature07965 · DOI · Paper page
  27. Shio, 2009, Malarial hemozoin activates the NLRP3 inflammasome through Lyn and Syk kinases, PLoS Pathog, 5, e1000559, 10.1371/journal.ppat.1000559 · DOI · Paper page
  28. Palomaki, 2011, Long, needle-like carbon nanotubes and asbestos activate the NLRP3 inflammasome through a similar mechanism, ACS Nano, 5, 6861, 10.1021/nn200595c · DOI · Paper page
  29. Bryant, 2009, Molecular mechanisms involved in inflammasome activation, Trends Cell Biol, 19, 455, 10.1016/j.tcb.2009.06.002 · DOI · Paper page
  30. Stehlik, 2003, The PAAD/PYRIN-only protein POP1/ASC2 is a modulator of ASC-mediated nuclear-factor-kappa B and pro-caspase-1 regulation, Biochem J, 373, 101, 10.1042/bj20030304 · DOI · Paper page
  31. Bedoya, 2007, Pyrin-only protein 2 modulates NF-kappaB and disrupts ASC:CLR interactions, J Immunol, 178, 3837, 10.4049/jimmunol.178.6.3837 · DOI
  32. Shenoy, 2012, GBP5 promotes NLRP3 inflammasome assembly and immunity in mammals, Science, 336, 481, 10.1126/science.1217141 · DOI · Paper page
  33. Bae, 2011, Crystal structure of NALP3 protein pyrin domain (PYD) and its implications in inflammasome assembly, J Biol Chem, 286, 39528, 10.1074/jbc.M111.278812 · DOI · Paper page
  34. Brough, 2003, Ca2+ stores and Ca2+ entry differentially contribute to the release of IL-1 beta and IL-1 alpha from murine macrophages, J Immunol, 170, 3029, 10.4049/jimmunol.170.6.3029 · DOI · Paper page
  35. Murakami, 2012, Critical role for calcium mobilization in activation of the NLRP3 inflammasome, Proc Natl Acad Sci USA, 109, 11282, 10.1073/pnas.1117765109 · DOI · Paper page
  36. Lee, 2012, The calcium-sensing receptor regulates the NLRP3 inflammasome through Ca(2+) and cAMP, Nature, 492, 123, 10.1038/nature11588 · DOI · Paper page
  37. Lopez-Castejon, 2012, Current status of inflammasome blockers as anti-inflammatory drugs, Expert Opin Investig Drugs, 21, 995, 10.1517/13543784.2012.690032 · DOI
  38. Arulkumaran, 2011, A potential therapeutic role for P2X7 receptor (P2X7R) antagonists in the treatment of inflammatory diseases, Expert Opin Investig Drugs, 20, 897, 10.1517/13543784.2011.578068 · DOI · Paper page
  39. Coll, 2011, The cytokine release inhibitory drug CRID3 targets ASC oligomerisation in the NLRP3 and AIM2 inflammasomes, PLoS One, 6, e29539, 10.1371/journal.pone.0029539 · DOI
  40. Juliana, 2010, Anti-inflammatory compounds parthenolide and Bay 11-7082 are direct inhibitors of the inflammasome, J Biol Chem, 285, 9792, 10.1074/jbc.M109.082305 · DOI · Paper page

Cited by

See all 204

Metadata

Authors
Haneklaus, M., O’Neill, L. A., & Coll, R. C.
Venue
Current Opinion in Immunology
Publisher
Elsevier BV
Published
2013-02
Volume
25
Issue
1
Pages
40-45
ISSN
0952-7915
DOI
10.1016/j.coi.2012.12.004
Cited by
204
References
15
Language
en
Licence
  • www.elsevier.com/tdm/userlicense/1.0/ (tdm)
  • www.elsevier.com/legal/tdmrep-license (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Modulatory mechanisms controlling the NLRP3 inflammasome in inflammation: recent developments. https://app.cochat.ai/papers/10.1016/j.coi.2012.12.004
The paper
Haneklaus, M., O’Neill, L. A., & Coll, R. C. (2013). Modulatory mechanisms controlling the NLRP3 inflammasome in inflammation: recent developments. Current Opinion in Immunology. https://doi.org/10.1016/j.coi.2012.12.004

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.